StockNews.com Begins Coverage on Retractable Technologies (NYSE:RVP)

Equities research analysts at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a report issued on Wednesday. The brokerage set a “hold” rating on the stock.

Retractable Technologies Price Performance

RVP opened at $0.62 on Wednesday. The stock has a fifty day moving average price of $0.71 and a 200 day moving average price of $0.93. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. Retractable Technologies has a 1 year low of $0.56 and a 1 year high of $1.34. The stock has a market cap of $18.41 million, a price-to-earnings ratio of -1.14 and a beta of 2.06.

Insider Transactions at Retractable Technologies

In other Retractable Technologies news, CEO Thomas J. Shaw acquired 71,422 shares of the firm’s stock in a transaction that occurred on Friday, September 20th. The stock was purchased at an average cost of $0.82 per share, for a total transaction of $58,566.04. Following the completion of the acquisition, the chief executive officer now owns 14,743,907 shares of the company’s stock, valued at approximately $12,090,003.74. This trade represents a 0.49 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders have acquired a total of 179,515 shares of company stock worth $143,037 in the last 90 days. 55.00% of the stock is owned by insiders.

Institutional Investors Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC acquired a new position in Retractable Technologies, Inc. (NYSE:RVP) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies at the end of the most recent quarter. Institutional investors and hedge funds own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.